🔍
Using Patient-Specific Modeling of the Heart for Prediction of Optimal Targets for Catheter Ablation of Ventricular Tachycardia in Patients with Myocardial Infarction or Fibrosis and ICDs
Case ID:
C13583
Report of Invention:
4/29/2015
Web Published:
10/9/2019
Unmet Need
Ventricular tachycardia (VT) is a heart rhythm disorder that affects hundreds of thousands of Americans every year. VT is defined as an irregular accelerated heart rate due to abnormal electrical signaling in the heart’s lower chambers. Implantable Cardioverter Defibrillators (ICDs) can protect high-risk patients from sudden cardiac arrest due to known/sustained VT by administering a controlled electrical shock when they detect a heart is beating much too quickly. As a means to reduce painful and unnecessary ICD shocks, catheter ablation is often a required adjunctive therapy for patients with VT. Despite significant clinical advances in techniques for VT ablation, success rates remain limited and a new technique for ICD patients is in high demand.
Technology Overview
New technologies have provided a non-invasive technique to identify optimal ablation in VT patients using 3D electrophysiological heart simulation via a reconstructed heart model. However, the approach uses MRI image mapping to model patients’ hearts and thus cannot be applied to people with ICDs as the implant creates an artifact in MRI images. The proposed technology overcomes this issue by estimating the image area affected by the artifact and includes it in the reconstructed 3D ventricular model. In addition, the technology includes a system to compare the predicted ablation sites to the clinical sites when used in a retrospective setting. This new ablation mechanism raises efficacy, shortens the duration of the procedure, and prevents excessive tissue damage during the procedure.
Stage of Development
The inventors have used this technique to perform both retrospective and prospective human studies.
Publications
A Prakosa, et al. Personalized virtual-heart technology for guiding the ablation of infarct-related ventricular tachycardia. Nature Biomed. Eng. 2, 732-740 (2018).
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Using Patient-Specific Modeling of the Heart for Prediction of Optimal Targets for Catheter Ablation of Ventricular Tachycardia in Patients with Myocardial Infarction or Fibrosis and ICDs
PCT: Patent Cooperation Treaty
PCT
PCT/US2016/032187
5/12/2016
Expired
SYSTEMS AND METHODS FOR PATIENT-SPECIFIC MODELING OF THE HEART FOR PREDICTION OF TARGETS FOR CATHETER ABLATION OF VENTRICULAR TACHYCARDIA IN PATIENTS WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
PCT: Patent Cooperation Treaty
United States
15/563,354
10,363,100
5/12/2016
7/30/2019
5/12/2036
Granted
Direct Link:
https://jhu.technologypublisher.com/technology/36503
Inventors:
Category(s):
Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Research Tools, Technology Classifications > Medical Devices, Technology Classifications > Therapeutic Modalities, Technology Classifications > Diagnostics,
Get custom alerts for techs in these categories/from these inventors:
Subscribe for JHTV Updates
For Information, Contact:
Lisa Schwier
lschwie2@jhu.edu
410-614-0300
Save This Technology:
Bookmark this page
Download as PDF
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum